These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34311082)
1. TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Sun Y; Ren D; Yang C; Yang W; Zhao J; Zhou Y; Jin X; Wu H Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166213. PubMed ID: 34311082 [TBL] [Abstract][Full Text] [Related]
2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
3. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523 [TBL] [Abstract][Full Text] [Related]
4. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595 [TBL] [Abstract][Full Text] [Related]
5. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Cai H; Zhao J; Zhang Q; Wu H; Sun Y; Guo F; Zhou Y; Qin G; Xia W; Zhao Y; Liang X; Yin S; Qin Y; Li D; Wu H; Ren D Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167183. PubMed ID: 38657551 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
8. FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. Su D; Wang R; Chen G; Ding C; Liu Y; Tao J; Wang Y; Qiu J; Luo W; Weng G; Yang G; Zhang T Cancer Res; 2024 Aug; 84(16):2607-2625. PubMed ID: 38775804 [TBL] [Abstract][Full Text] [Related]
9. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells. Li J; Ke J; Fang J; Chen JP J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239 [TBL] [Abstract][Full Text] [Related]
10. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis. Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597 [TBL] [Abstract][Full Text] [Related]
11. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
12. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798 [TBL] [Abstract][Full Text] [Related]
13. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7. Xu C; Qi X J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206 [TBL] [Abstract][Full Text] [Related]
14. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway. Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774 [No Abstract] [Full Text] [Related]
16. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma. Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693 [TBL] [Abstract][Full Text] [Related]
17. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice. Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697 [TBL] [Abstract][Full Text] [Related]
18. LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma. Acier A; Godard M; Gassiot F; Finetti P; Rubis M; Nowak J; Bertucci F; Iovanna JL; Tomasini R; Lécorché P; Jacquot G; Khrestchatisky M; Temsamani J; Malicet C; Vasseur S; Guillaumond F Commun Biol; 2021 Aug; 4(1):987. PubMed ID: 34413441 [TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718 [TBL] [Abstract][Full Text] [Related]
20. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]